AZD1480 is primarily used in research settings to study its effects on cancer and inflammatory diseases. It functions as a JAK2 inhibitor, targeting pathways involved in cell signaling and proliferation. Researchers are exploring its potential to inhibit tumor growth, particularly in cancers where JAK2 signaling is dysregulated, such as certain types of leukemia and solid tumors. Additionally, AZD1480 is being investigated for its role in modulating immune responses, making it a candidate for treating autoimmune conditions and chronic inflammatory diseases. Its application in preclinical studies has provided insights into its mechanism of action and potential therapeutic benefits, though further clinical trials are needed to establish its efficacy and safety in humans.